The Division of Pediatric Hematology Oncology has two positions available for a first-year fellow in pediatric hematology oncology starting July 8, 2021. The program is a three-year ACGME-accredited clinical training program in a dynamic urban setting with opportunities to train in a tertiary/quaternary referral center as well as in community hospital locations.
Program Goals: to produce a well-trained pediatric hematologist oncologist who is capable of conducting independent research. Opportunities are available for research training and scholarly activity in clinical, translational or basic science research.
Interested applicants should submit the following:
Curriculum vitae
Personal statement
Medical school transcript and/or MSPE, if applicable
Three letters of recommendation
Application materials should be sent to Alice del Rosario (adelrosario@mednet.ucla.edu), Fellowship Program Coordinator.
Prerequisite training: The applicant must possess an M.D. or D.O. degree from a U.S. or Canadian medical school or be ECFMG-certified if an international medical graduate. The applicant must have completed three years of a pediatric residency in an approved training program. Trainees must successfully pass all three steps of the U.S. Medical Licensing Exam (USMLE) including the clinical skills portion. Fellows must be able to obtain an unrestricted California medical license prior to beginning fellowship training. Ideally, candidates should have completed residency training in the U.S.
NOTES:
2 openings. Employer will assist with relocation costs.
Additional Salary Information: Trainees receive an additional housing stipend of $12,000, relocation reimbursement up to $2,750 if greater than 50 miles; educational expenses up to $1000 per year and meal allowance per year.
Internal Number: PHO-F-2021
About UCLA Health
UCLA pediatricians provide world-class patient care using a family-centered care model. As part of an academic medical center, our doctors have access to advanced diagnostics, treatments, and research that may not yet be widely available elsewhere.
